Stocks and Investing
Stocks and Investing
Thu, September 23, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Narumi Nakagiri Downgraded (AMGN) to Hold and Held Target at $220 on, Sep 23rd, 2021
Narumi Nakagiri of Daiwa Capital, Downgraded "Amgen Inc." (AMGN) to Hold and Held Target at $220 on, Sep 23rd, 2021.
Narumi has made no other calls on AMGN in the last 4 months.
There are 3 other peers that have a rating on AMGN. Out of the 3 peers that are also analyzing AMGN, 2 agree with Narumi's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $251 on, Tuesday, September 7th, 2021
- Geoffrey Porges of "SVB Leerink" Maintained at Hold with Decreased Target to $234 on, Wednesday, August 4th, 2021
This is the rating of the analyst that currently disagrees with Narumi
- Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $277 on, Monday, June 7th, 2021
Contributing Sources